331 related articles for article (PubMed ID: 19105332)
1. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
[TBL] [Abstract][Full Text] [Related]
2. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
6. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
7. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
Moritani S; Sugihara H; Kushima R; Hattori T
Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
11. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
Han J; He D; Feng ZY; Ding YG; Shao CK
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients.
Karim N; Pallesen G
Malays J Pathol; 2003 Jun; 25(1):45-7. PubMed ID: 16196377
[TBL] [Abstract][Full Text] [Related]
15. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
[TBL] [Abstract][Full Text] [Related]
16. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas.
Shibosawa E; Tsutsumi K; Koizuka I; Hoshikawa M; Takakuwa T
Laryngoscope; 2000 Jan; 110(1):93-7. PubMed ID: 10646722
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
[TBL] [Abstract][Full Text] [Related]
18. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y
J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]